TW · Healthcare

Sinphar Pharmaceutical Co Ltd (1734)

Biotechnology

Sinphar Pharmaceutical Co Ltd (1734) is listed on TW in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 1734

P/E ratio

25.00

Sinphar Pharmaceutical Co Ltd (1734) — FAQ

What is 1734's P/E ratio?

The price-to-earnings (P/E) ratio for Sinphar Pharmaceutical Co Ltd (1734) is 25.00 (data as of 2026-05-23).

Does Sinphar Pharmaceutical Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Sinphar Pharmaceutical Co Ltd (1734). Check the MyAverix Finance app for the latest dividend data.

What sector is Sinphar Pharmaceutical Co Ltd in?

Sinphar Pharmaceutical Co Ltd (1734) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 1734 listed on?

1734 is listed on TW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)